A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at...
... alkylating agents (e.g., cyclophosphamide or chlorambucil), or mycophenolate. *Treatment with a calcineurin inhibitor within 2 ... Treatment with other immunomodulatory agents within 6 months of randomization including, but not limited to, complement ...